Prevexxion RN+HVT RSSAuthorisedThis medicine is authorised for use in the European UnionMarek’s disease virus, strain RN1250, live / turkey herpesvirus, strain FC126, LiveMedicineVeterinaryAuthorised
Page contentsPage contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on Prevexxion RN+HVTApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Prevexxion RN+HVT Active substance Marek’s disease virus, strain RN1250, liveturkey herpesvirus, strain FC126, Live International non-proprietary name (INN) or common name Marek’s disease virus, strain RN1250, liveturkey herpesvirus, strain FC126, LivePharmacotherapeutic groupImmunologicals for avesLive viral vaccinesAvian herpes virus (marek's disease)Authorisation details EMA product number EMEA/V/C/006146 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Prevexxion RN+HVTAdoptedReference Number: EMA/CVMP/398578/2023 English (EN) (119.43 KB - PDF)First published: 08/09/2023ViewNews on Prevexxion RN+HVTMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 December 202406/12/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 202308/09/2023This page was last updated on 11/03/2024Share this page